Taiyi Guanjia Secures RMB 920 Million Strategic Financing to Deepen Health Management Services

VCBeat has learned thatOn May 8, Shanghai Shantai Health Technology Co., Ltd. (hereinafter referred to as “Taiyi Guanjia”) announced the completion of its strategic Series F financing round, raising RMB 920 million. The round was jointly led by new investors Shanghai International Group Asset Management Co., Ltd. and Mitsui Sumitomo Insurance, with existing shareholders China Pacific Insurance (Group) Co., Ltd. and HongShan continuing to increase their investments.

Since its establishment over three years ago, Taiyi Guanjia has leveraged family doctor services as an entry point and medical services as a vehicle to deeply cultivate insurance scenarios, meeting users’ demands for upgraded healthcare consumption. Its cumulative sales have surpassed RMB 700 million. The funds raised in this round of financing will be used to continuously refine core capabilities, enhance the scope of family doctor services, establish itself as the primary gateway for user health services, and achieve precise matching of multi-tiered medical services.

For this round of financing,Xu Jing, CEO of Taiyi GuanjiaIt stated: “In the implementation and practice of managed care, Taiyi Guanjia has achieved a leap from its initial stages to rapid development. In particular, with the maturation of the family doctor system and the accelerated integration with insurance services, an innovative development model for delivering service capabilities has taken shape. By fostering mutual integration and collaborative promotion with upstream and downstream partners, the company has continuously achieved results in new product development and commercialization, thereby consolidating and enhancing its core competitiveness. Looking ahead, Taiyi Guanjia will continue to focus on the health services sector, driving the ongoing deepening of one-stop health services toward greater personalization, thereby creating greater value for users.”

Shanghai International Asset ManagementIt was stated that healthcare is a key focus area for Shanghai International Group Asset Management Co., Ltd. Amidst the overarching trend of building a multi-tiered medical security system, we are also seeking opportunities to promote high-quality and efficient development of the broader health industry. As a one-stop platform for family doctor services and managed care, Taiyi Guanjia focuses on innovative development driven by “technology + healthcare,” aggregates high-quality medical resources, deeply integrates into diverse user scenarios, continuously innovates, and empowers the insurance industry. We remain long-term bullish on the commercial value derived from the deep integration of insurance and healthcare service scenarios.

Mitsui Sumitomo Insurancestated that China Pacific Insurance (CPIC) has been our strategic partner for nearly two decades. Through this mutual integration, we believe that Taiyi Guanjia, leveraging its high-quality medical resources, will help establish a stable cooperative relationship between both parties in the broader health sector, jointly promoting the development and innovation of health insurance business, and contributing to the initiatives of "Healthy China" and global health.

China Pacific InsuranceIt stated that in recent years, China Pacific Insurance (CPIC) has adhered to a path of high-quality development, adopted a customer-centric approach, and actively positioned itself in the broader health industry. By integrating the “medical care, pharmaceuticals, and insurance” closed loop, CPIC has strived to build an integrated medical-health ecosystem comprising health management, insurance products, and medical services, thereby providing customers with health management services covering their entire life cycle. This financing represents another significant step for CPIC in implementing the “Healthy China” strategy, upgrading its layout in the health industry, and enhancing the capabilities of its “CPIC Service.”

HongShanstated, “We have long been committed to investing in outstanding companies in the healthcare sector. There are significant synergies between Taiyi Guanjia and commercial insurance companies; by integrating insurance with health services, we can enhance users’ sense of value and security. HongShan’s extensive portfolio ecosystem and professional post-investment support team will also facilitate Taiyi Guanjia’s long-term development.”

The widespread adoption and implementation of managed care concepts can further unlock the value of high-quality online and offline medical resources, enhance societal healthcare efficiency, and provide differentiated services to meet the needs of diverse population segments. Leveraging new financial and resource support, Taiyi Guanjia will continue to explore the practical implementation of managed care in China, continuously innovate and iterate its healthcare service capabilities and risk reduction management capabilities, facilitate ongoing industry transformation, improve the healthcare service ecosystem, and promote healthy living for all.

Shanghai International Group Asset Management Co., Ltd. (hereinafter referred to as “Shanghai International Asset Management”) is a wholly-owned subsidiary of Shanghai International Group. It serves as the core entity for Shanghai International Group’s investment management operations and functions as a competitive business entity that manages social capital through market-oriented mechanisms, thereby leveraging, amplifying, and driving the influence of state-owned capital. Its predecessor, Shanghai Shangtou Industrial Company, was established in 1987, renamed Shanghai International Group Investment Management Co., Ltd. in 2006, and underwent integration and restructuring at the end of 2008. The company currently has a registered capital of RMB 3.5 billion. Since its establishment, Shanghai International Asset Management has accumulated nearly three decades of experience in equity investment, having developed and invested in over one hundred medium-to-large equity projects across industries such as finance, real estate, pharmaceuticals, high-end manufacturing, and semiconductors. As a major shareholder, it has initiated and established multiple industrial funds and fund-of-funds management companies, including Jinpu Industrial Investment Fund Management Co., Ltd., Shanghai Guohe Modern Service Industry Equity Investment Management Co., Ltd., and Shanghai Guofang Fund-of-Funds Equity Investment Management Co., Ltd.

Mitsui Sumitomo Insurance is a core non-life insurance company under the MS&AD Insurance Group, which ranks among the Fortune Global 500 and is the largest non-life insurance group in Japan. Currently, Mitsui Sumitomo Insurance operates non-life insurance businesses in 42 countries and regions worldwide, boasting a world-class network. Notably, it is the only non-life insurer capable of conducting direct insurance operations in all ASEAN countries. In China, the company established a strategic partnership with China Pacific Insurance (Group) Co., Ltd. in 2004. Today, Mitsui Sumitomo Insurance has a subsidiary in Shanghai, providing property insurance and risk management services to customers through its branches in Beijing, Shanghai, Guangzhou, Wuxi, Shenzhen, and Suzhou.

China Pacific Insurance (Group) Co., Ltd. (hereinafter referred to as “Pacific Insurance”) is an insurance group company established on the basis of China Pacific Insurance Company, which was founded on May 13, 1991. As a leading comprehensive insurance group in China, it is the first insurance company to be listed in three places: A-shares (Shanghai), H-shares (Hong Kong), and GDRs (London). Pacific Insurance holds full insurance licenses covering life insurance, property insurance, pension insurance, health insurance, agricultural insurance, and asset management, providing customers with comprehensive risk protection solutions, wealth planning, and asset management services.

HongShan is a private equity investment firm focused on three key sectors: technology, healthcare, and consumer industries. Since its establishment in 2005, HongShan has been committed to identifying and nurturing innovative and entrepreneurial forces, having invested in over 1,500 companies both domestically and internationally. Among these portfolio companies, many have emerged with distinct technological advantages, innovative business models, and high growth potential. To date, more than 160 of HongShan’s portfolio companies have successfully gone public, and nearly 130 private companies have grown into unicorns.